CV Sciences (CVSI) Amortizatization of Intangibles (2013 - 2026)
CV Sciences' (CVSI) quarterly Amortizatization of Intangibles came in at $65000.0 in Q1 2026, up 25.0% year-on-year from $52000.0 in Q1 2025, and down 48.82% quarter-over-quarter from $127000.0 in Q4 2025.
CV Sciences (CVSI) Amortizatization of Intangibles (2013 - 2026) Analysis & Trends
CV Sciences has disclosed Amortizatization of Intangibles across 9 years of filings, most recently posting $65000.0 for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $65000.0, up 25.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $526000.0 (up 202.3% YoY), and the FY2025 annual result was $513000.0, up 320.49% from the prior year.
- Amortizatization of Intangibles came in at $65000.0 for Q1 2026 at CV Sciences, down from $127000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $227000.0 in Q2 2025 to a low of $5000.0 in Q4 2024.
- The 4-year median for Amortizatization of Intangibles is $86000.0 (2025), against an average of $91000.0.
- Across the five-year window, Amortizatization of Intangibles tumbled 82.14% in 2024 and soared 2440.0% in 2025, its largest moves.
- CV Sciences' Amortizatization of Intangibles stood at $28000.0 in 2023, then sank by 82.14% to $5000.0 in 2024, then jumped by 2440.0% to $127000.0 in 2025, then plunged by 48.82% to $65000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $65000.0 (Q1 2026), $127000.0 (Q4 2025), and $107000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | CV Sciences | - | - | 1.56 Mn | 65,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65,000.00 |
| Mar 31, 2026 | 65,000.00 |
| Dec 31, 2025 | 127,000.00 |
| Dec 31, 2025 | 127,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Jun 30, 2025 | 227,000.00 |
| Jun 30, 2025 | 227,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 117,000.00 |
| Sep 30, 2024 | 117,000.00 |
| Dec 31, 2023 | 28,000.00 |
| Dec 31, 2023 | 28,000.00 |
| Jun 30, 2018 | 37,000.00 |
| Jun 30, 2018 | 37,000.00 |
| Mar 31, 2018 | 13,000.00 |
| Mar 31, 2018 | 13,000.00 |